|
Volumn 14, Issue 3, 2000, Pages 325-
|
Is post-exposure prophylaxis affordable?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
COST BENEFIT ANALYSIS;
DRUG COST;
HIGH RISK PATIENT;
HOMOSEXUALITY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
MALE;
PRIORITY JOURNAL;
PROPHYLAXIS;
UNITED STATES;
|
EID: 0034104596
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: 10.1097/00002030-200002180-00016 Document Type: Letter |
Times cited : (12)
|
References (5)
|